Oxymed Australia Fined by TGA over COVID-19 Advertising Claims

Australia’s Therapeutic Goods Administration (TGA) fined Oxymed Australia A$63,000 ($40,000) for making false claims that its hyperbaric oxygen therapy chambers can treat a variety of conditions, including COVID-19.

Oxymed’s claims are prohibited under therapeutic goods legislation and are “of significant concern to the TGA during the current pandemic,” the agency said.

The devices are not listed on the Australian Register of Therapeutic Goods, and unless an exemption applies, they cannot be legally supplied or advertised in Australia, the agency said.